Folliculitis Decalvans Responsive to Tofacitinib: A Case Series

    July 2020 in “ Dermatologic Therapy ”
    Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho … Rodney Sinclair
    Studysummary Tofacitinib may effectively treat folliculitis decalvans.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on minerva-access.unimelb.edu.au →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Successful Treatment of Refractory Folliculitis Decalvans with Secukinumab Australasian Journal of Dermatology · 2019
    2. Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients Journal of The American Academy of Dermatology · 2016
    3. Pharmacologic Inhibition of JAK-STAT Signaling Promotes Hair Growth Science Advances · 2015
    4. Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-Standing Cases Journal of Cutaneous Medicine and Surgery · 2015
    5. Lichen Planopilaris Is Characterized By Immune Privilege Collapse Of The Hair Follicle's Epithelial Stem Cell Niche The Journal of Pathology · 2013
    6. Management of Primary Cicatricial Alopecias: Options for Treatment British Journal of Dermatology · 2008